成人肝移植:英国临床指南第2部分手术与术后管理

2020-09-01 Frontline Gastroenterol . 2020 Feb 25;11(5):385-396

肝移植后患者的存活率在12个月时超过90%,在10年时接近70%。该指南的第1部分涉及到了肝移植的各个方面,直至被列入候补名单。第2部分说明器官分配过程,器官捐赠和器官类型以及这如何影响接受者的选择。

中文标题:

成人肝移植:英国临床指南第2部分手术与术后管理

英文标题:

Adult liver transplantation: UK clinical guideline - part 2: surgery and post-operation

发布机构:

发布日期:

2020-09-01

简要介绍:

肝移植后患者的存活率在12个月时超过90%,在10年时接近70%。该指南的第1部分涉及到了肝移植的各个方面,直至被列入候补名单。第2部分说明器官分配过程,器官捐赠和器官类型以及这如何影响接受者的选择。在分配器官之后,必须将移植手术和关键的术后早期限制在肝移植单位内。但是,患者最终将返回其转诊二级保健中心,需要进行持续的监督。本指南的第2部分涉及非移植专家在肝移植后护理中的三个关键领域:(1)监督免疫抑制作用,包括相互作用和依从性; (2)移植的器官以及如何启动器官功能障碍的调查; (3)仔细监督其他器官系统,包括优化肾功能,心血管健康和社会心理影响。随着时间的流逝,这种整体方法的关键意义变得更加明显,那时患者应该期望应对越来越多的非肝脏后果的责任在于初级和二级护理。

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6c94f1c0019e1a87, title=成人肝移植:英国临床指南第2部分手术与术后管理, enTitle=Adult liver transplantation: UK clinical guideline - part 2: surgery and post-operation, guiderFrom=Frontline Gastroenterol . 2020 Feb 25;11(5):385-396, authorId=0, author=, summary=肝移植后患者的存活率在12个月时超过90%,在10年时接近70%。该指南的第1部分涉及到了肝移植的各个方面,直至被列入候补名单。第2部分说明器官分配过程,器官捐赠和器官类型以及这如何影响接受者的选择。, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Sep 01 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>肝移植后患者的存活率在12个月时超过90%,在10年时接近70%。该指南的第1部分涉及到了肝移植的各个方面,直至被列入候补名单。第2部分说明器官分配过程,器官捐赠和器官类型以及这如何影响接受者的选择。在分配器官之后,必须将移植手术和关键的术后早期限制在肝移植单位内。但是,患者最终将返回其转诊二级保健中心,需要进行持续的监督。本指南的第2部分涉及非移植专家在肝移植后护理中的三个关键领域:(1)监督免疫抑制作用,包括相互作用和依从性; (2)移植的器官以及如何启动器官功能障碍的调查; (3)仔细监督其他器官系统,包括优化肾功能,心血管健康和社会心理影响。随着时间的流逝,这种整体方法的关键意义变得更加明显,那时患者应该期望应对越来越多的非肝脏后果的责任在于初级和二级护理。</p>, tagList=[TagDto(tagId=2276, tagName=肝移植)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2170, appHits=132, showAppHits=0, pcHits=621, showPcHits=2038, likes=3, shares=19, comments=9, approvalStatus=1, publishedTime=Sun Sep 13 20:07:38 CST 2020, publishedTimeString=2020-09-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sun Sep 13 20:07:32 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Fri Jan 05 23:58:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1070181, encodeId=8e3a10e0181a4, content=nice, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=befe5704258, createdName=ms9000000410256940, createdTime=Sun Nov 14 16:13:33 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069425, encodeId=0f81106942541, content=不错!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Nov 12 00:33:39 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885869, encodeId=6c6988586921, content=<a href='/topic/show?id=565b813185f' target=_blank style='color:#2F92EE;'>#肝移植#</a>指南,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81318, encryptionId=565b813185f, topicName=肝移植)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 16 20:46:00 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885208, encodeId=e479885208e3, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WNTO2r1ic0ib3uqg4axnKO7VUO3WHqcibhsXpcmv06picZveX3pxGk2JT2KLo4kuPfb0yFJZguu7Ye6L5NzbMGKCIw/132, createdBy=27b82547501, createdName=遥遥领先, createdTime=Mon Sep 14 17:19:37 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885197, encodeId=008788519ed4, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0G2KQrJ4107mFibibIPvibGXUfBtcINMCMKUo6Ju0Eha3sOLZJRDgDGu4ALqpvYc6V6yYgjPXFGFz6XnxCSkiawbBQ/132, createdBy=7b375251607, createdName=sinze, createdTime=Mon Sep 14 16:31:12 CST 2020, time=2020-09-14, status=1, ipAttribution=)]
    2021-11-14 ms9000000410256940

    nice

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1070181, encodeId=8e3a10e0181a4, content=nice, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=befe5704258, createdName=ms9000000410256940, createdTime=Sun Nov 14 16:13:33 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069425, encodeId=0f81106942541, content=不错!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Nov 12 00:33:39 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885869, encodeId=6c6988586921, content=<a href='/topic/show?id=565b813185f' target=_blank style='color:#2F92EE;'>#肝移植#</a>指南,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81318, encryptionId=565b813185f, topicName=肝移植)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 16 20:46:00 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885208, encodeId=e479885208e3, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WNTO2r1ic0ib3uqg4axnKO7VUO3WHqcibhsXpcmv06picZveX3pxGk2JT2KLo4kuPfb0yFJZguu7Ye6L5NzbMGKCIw/132, createdBy=27b82547501, createdName=遥遥领先, createdTime=Mon Sep 14 17:19:37 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885197, encodeId=008788519ed4, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0G2KQrJ4107mFibibIPvibGXUfBtcINMCMKUo6Ju0Eha3sOLZJRDgDGu4ALqpvYc6V6yYgjPXFGFz6XnxCSkiawbBQ/132, createdBy=7b375251607, createdName=sinze, createdTime=Mon Sep 14 16:31:12 CST 2020, time=2020-09-14, status=1, ipAttribution=)]
    2021-11-12 ms2000001789660809

    不错!!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1070181, encodeId=8e3a10e0181a4, content=nice, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=befe5704258, createdName=ms9000000410256940, createdTime=Sun Nov 14 16:13:33 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069425, encodeId=0f81106942541, content=不错!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Nov 12 00:33:39 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885869, encodeId=6c6988586921, content=<a href='/topic/show?id=565b813185f' target=_blank style='color:#2F92EE;'>#肝移植#</a>指南,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81318, encryptionId=565b813185f, topicName=肝移植)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 16 20:46:00 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885208, encodeId=e479885208e3, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WNTO2r1ic0ib3uqg4axnKO7VUO3WHqcibhsXpcmv06picZveX3pxGk2JT2KLo4kuPfb0yFJZguu7Ye6L5NzbMGKCIw/132, createdBy=27b82547501, createdName=遥遥领先, createdTime=Mon Sep 14 17:19:37 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885197, encodeId=008788519ed4, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0G2KQrJ4107mFibibIPvibGXUfBtcINMCMKUo6Ju0Eha3sOLZJRDgDGu4ALqpvYc6V6yYgjPXFGFz6XnxCSkiawbBQ/132, createdBy=7b375251607, createdName=sinze, createdTime=Mon Sep 14 16:31:12 CST 2020, time=2020-09-14, status=1, ipAttribution=)]
    2020-09-16 lovetcm

    #肝移植#指南,值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1070181, encodeId=8e3a10e0181a4, content=nice, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=befe5704258, createdName=ms9000000410256940, createdTime=Sun Nov 14 16:13:33 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069425, encodeId=0f81106942541, content=不错!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Nov 12 00:33:39 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885869, encodeId=6c6988586921, content=<a href='/topic/show?id=565b813185f' target=_blank style='color:#2F92EE;'>#肝移植#</a>指南,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81318, encryptionId=565b813185f, topicName=肝移植)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 16 20:46:00 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885208, encodeId=e479885208e3, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WNTO2r1ic0ib3uqg4axnKO7VUO3WHqcibhsXpcmv06picZveX3pxGk2JT2KLo4kuPfb0yFJZguu7Ye6L5NzbMGKCIw/132, createdBy=27b82547501, createdName=遥遥领先, createdTime=Mon Sep 14 17:19:37 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885197, encodeId=008788519ed4, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0G2KQrJ4107mFibibIPvibGXUfBtcINMCMKUo6Ju0Eha3sOLZJRDgDGu4ALqpvYc6V6yYgjPXFGFz6XnxCSkiawbBQ/132, createdBy=7b375251607, createdName=sinze, createdTime=Mon Sep 14 16:31:12 CST 2020, time=2020-09-14, status=1, ipAttribution=)]
    2020-09-14 遥遥领先

    很不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1070181, encodeId=8e3a10e0181a4, content=nice, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=befe5704258, createdName=ms9000000410256940, createdTime=Sun Nov 14 16:13:33 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069425, encodeId=0f81106942541, content=不错!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18045418262, createdName=ms2000001789660809, createdTime=Fri Nov 12 00:33:39 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885869, encodeId=6c6988586921, content=<a href='/topic/show?id=565b813185f' target=_blank style='color:#2F92EE;'>#肝移植#</a>指南,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81318, encryptionId=565b813185f, topicName=肝移植)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 16 20:46:00 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885208, encodeId=e479885208e3, content=很不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WNTO2r1ic0ib3uqg4axnKO7VUO3WHqcibhsXpcmv06picZveX3pxGk2JT2KLo4kuPfb0yFJZguu7Ye6L5NzbMGKCIw/132, createdBy=27b82547501, createdName=遥遥领先, createdTime=Mon Sep 14 17:19:37 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885197, encodeId=008788519ed4, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0G2KQrJ4107mFibibIPvibGXUfBtcINMCMKUo6Ju0Eha3sOLZJRDgDGu4ALqpvYc6V6yYgjPXFGFz6XnxCSkiawbBQ/132, createdBy=7b375251607, createdName=sinze, createdTime=Mon Sep 14 16:31:12 CST 2020, time=2020-09-14, status=1, ipAttribution=)]
    2020-09-14 sinze

    谢谢分享

    0